ME Therapeutics Holdings Statistics

Total Valuation

CSE:METX has a market cap or net worth of CAD 75.12 million. The enterprise value is 73.94 million.

Market Cap	75.12M
Enterprise Value	73.94M

Important Dates

The next estimated earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:METX has 30.05 million shares outstanding. The number of shares has increased by 16.39% in one year.

Current Share Class	30.05M
Shares Outstanding	30.05M
Shares Change (YoY)	+16.39%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	56.35%
Owned by Institutions (%)	n/a
Float	13.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	72.00
P/TBV Ratio	72.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-55.36
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-58.68

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.04.

Current Ratio	6.12
Quick Ratio	5.65
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-144.48

Financial Efficiency

Return on equity (ROE) is -82.48% and return on invested capital (ROIC) is -54.57%.

Return on Equity (ROE)	-82.48%
Return on Assets (ROA)	-52.06%
Return on Invested Capital (ROIC)	-54.57%
Return on Capital Employed (ROCE)	-141.37%
Weighted Average Cost of Capital (WACC)	5.45%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.75% in the last 52 weeks. The beta is 0.22, so CSE:METX's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-68.75%
50-Day Moving Average	4.01
200-Day Moving Average	5.29
Relative Strength Index (RSI)	42.93
Average Volume (20 Days)	655

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.48M
Pretax Income	-1.34M
Net Income	-1.34M
EBITDA	-1.45M
EBIT	-1.48M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 856,670 in cash and 42,457 in debt, giving a net cash position of 814,213 or 0.03 per share.

Cash & Cash Equivalents	856,670
Total Debt	42,457
Net Cash	814,213
Net Cash Per Share	0.03
Equity (Book Value)	1.04M
Book Value Per Share	0.03
Working Capital	809,722

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.18 million and capital expenditures -84,512, giving a free cash flow of -1.26 million.

Operating Cash Flow	-1.18M
Capital Expenditures	-84,512
Depreciation & Amortization	26,778
Net Borrowing	-65,948
Free Cash Flow	-1.26M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:METX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.39%
Shareholder Yield	-16.39%
Earnings Yield	-1.78%
FCF Yield	-1.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1